Driving Compliance, Integrity, and Acceleration Across the Biotechnology Lifecycle
Accelerate biopharmaceutical innovation and safeguard advanced therapies with QCLYNX’s risk-based compliance, validation, and quality solutions. Tailored for high-complexity biotech operations, our services mitigate biological processing risks, preserve data integrity, and guarantee continuous audit readiness—from discovery and translational R&D to commercial biomanufacturing.
Quality & Compliance Excellence for the Next-Gen Biotechnology Industry
The biotechnology sector is expanding exponentially—shifting rapidly from standard recombinant proteins to complex cell and gene therapies (CGTs), mRNA platforms, monoclonal antibodies, and continuous biomanufacturing. However, advanced biological products bring heightened regulatory scrutiny. Regulatory authorities enforce strict oversight, where minor process variations, contamination risks, or data integrity gaps can lead to clinical holds, rejected Biologics License Applications (BLAs), and severe financial setbacks. Biotech innovators must balance aggressive drug-development timelines with total regulatory compliance. QCLYNX serves as a trusted compliance partner for biotechnology companies. We turn complex regulatory mandates into operational advantages by implementing GAMP® 5 risk-based validation models, streamlining digital workflows, and protecting critical bioprocess data across every stage of development.
Our Core Offerings
Trusted Services for Biotechnology Industry
Biotech Computer System Validation (CSV) & Computer Software Assurance (CSA)
Risk-based validation for GxP digital systems, automated bioreactor controls, and cloud platforms compliant with FDA 21 CFR Part 11 and EU Annex 11.
Bioprocess & Cleanroom Qualification
Environmental monitoring setup, cleanroom qualification, and automated equipment validation (bioreactors, chromatography units, ultrafiltration systems).
Data Integrity & GxP Migration Services
End-to-end ALCOA+ data flow mapping, legacy database migration, and audit trail verification for R&D and manufacturing databases.
Biotech GxP Audits & Supply Chain Governance
Targeted supplier and CMO/CRO audits evaluating raw biological material traceability, cold-chain logistics, and viral safety compliance.
Quality System Setup & Regulatory Inspection Readiness
Turnkey eQMS rollout, SOP development, mock regulatory inspections, and post-audit CAPA management for biotech startups and scaling operations.
We are here to help you.
End-to-End Product Lifecycle Partnership
Building on proven life science leadership, QCLYNX empowers biotechnology innovators by leveraging high-efficiency validation tools and agile methodologies. Driven by a commitment to regulatory excellence, we continuously adapt our capabilities to ensure cell therapy developers, biologics manufacturers, and genetic medicine pioneers achieve seamless, audit-ready global market entry.
We enforce ALCOA+ principles across all bioprocess tools. This includes performing data flow mapping from raw instrument output to final analytics, securing electronic records in cloud repositories, and establishing automated audit trail reviews for continuous compliance.
Yes. We design scalable Quality Management Systems (QMS) and risk-based validation frameworks (CSA) that grow alongside your pipeline, allowing early-stage biotech companies to stay lean while building inspection-ready documentation.
We conduct full-scope GxP audits focused on biological raw material traceability, vector manufacturing protocols, cold-chain monitoring, and vendor software validation to minimize supply chain vulnerabilities
We validate a complete suite of biotech systems, including Electronic Lab Notebooks (ELN), Laboratory Information Management Systems (LIMS), Bioprocess SCADA/PLC software, Quality Management Systems (eQMS), and Enterprise Resource Planning (ERP) solutions.